Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Similar documents
ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Hindustan Media Ventures

Amber Enterprises India Ltd

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

Procter & Gamble Hygiene & Health Care

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Mahindra & Mahindra Ltd.

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Mahindra & Mahindra Ltd.

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

JK Lakshmi Cement BUY. Performance Highlights CMP. `63 Target Price `79. 4QFY2012 Result Update Cement. Investment Period 12 Months

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

Transport Corporation of India

Mahindra & Mahindra Ltd.

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

Quick take. Aditya Birla Nuvo BUY. Deep Value. Valuation Methodology. Exhibit 1: ABNL s Business Structure

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Century Plyboards Ltd

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

Quick take. VIP Industries BUY. Travelling smart on the luggage track. CMP Target Price `153 ` year daily price chart

Quick take. Ashok Leyland Ltd BUY. Scrappage policy to drive faster growth. Target Price. Investment Period 12 Months. 3-year price chart

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

Visaka Industries BUY. Performance Highlights CMP. `119 Target Price `144. 2QFY2016 Result Update Cement Products. Investment Period 12 Months

Prakash Industries BUY. Performance Highlights. CMP Target Price `81 `124. 3QFY2011 Result Update Steel

Cairn India ACCUMULATE. Performance Highlights. CMP Target Price `338 `382. 2QFY2013 Result Update Oil & Gas. Quarterly highlights (Consolidated)

Matrimony.com Ltd BUY. A complete package from matchmaking to wedding. Target Price. Initiating Coverage Internet Software & Services

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

Alembic BUY. Performance Highlights. Target Price. 1QFY2011 Result Update Pharmaceutical. Investment Period 12 months

Tata Consultancy Services (TCS)

Dr. Reddy s Laboratories

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

TV Today Network BUY. Go with the market leader. CMP Target Price `297 `363. Initiating Coverage Media. 3-year price chart

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `390 Target Price - 2QFY2017 Result Update Pharmaceutical. Investment Period -

Dewan Housing Finance

ITD Cementation India

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `440 Target Price. 3QFY2017 Result Update Pharmaceutical. Investment Period -

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `7,622 Target Price `8,501. 1QFY2018 Result Update Automobile

Aurobindo Pharma ACCUMULATE. Performance Highlights. `780 Target Price CMP `855. 2QFY2019 Result Update Pharmaceutical. Investment Period 12 months

MISHRA DHATU NIGAM Ltd.

Cadila Healthcare ACCUMULATE. Performance Highlights. CMP 860 Target Price QFY2013 Result Update Pharmaceutical. Key financials (Consolidated)

Simplex Infrastructures

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Apollo Micro Systems Ltd

Goodyear India BUY. Performance Highlights. CMP Target Price `487 `582. 4QFY2016 Result Update Tyres. 3-year Daily Price Chart.

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Lupin BUY. Performance Highlights. CMP `1,493 Target Price `1,809. 2QFY2017 Result Update Pharmaceutical. 3-year price chart

Varroc Engineering Ltd.

Future Supply Chain Solutions Ltd

GlaxoSmithKline Pharmaceuticals

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Lupin 1QFY2018 Result Update

Newgen Software Technologies Ltd

Sun Pharma BUY. Performance Highlights. `739 Target Price `944 CMP. 4QFY2016 Result Update Pharmaceutical. Investment Period 12 months

TVS Motor Company BUY. Performance Highlights. CMP Target Price `39 `45. 2QFY2013 Result Update Automobile. Quarterly highlights (Standalone)

BGR Energy Systems NEUTRAL. Performance Highlights CMP. `235 Target Price - 3QFY2013 Result Update Capital Goods. Investment Period -

MRF BUY. Performance Highlights. CMP `40,703 Target Price `47,548. 1QSY2015 Result Update Tyre

Transcription:

Ambuja Cements Performance Highlights Quarterly results (Standalone) Y/E Dec. (` cr) 3QCY2015 2QCY2015 % chg qoq 3QCY2014 % chg yoy Net Sales 2,095 2,493 (16.0) 2,188 (4.2) EBIDTA 310 384 (19.2) 393 (21.2) EBIDTA Margin (%) 14.7 15.4 (70bp) 17.9 (317bp Net Profit 154 226 (32.2) 239 (35.8) For 3QCY2015, Ambuja Cements (ACEM) reported an in line set of numbers on the operational front. The company reported a 1.7% yoy growth in cement volumes to 4.9mt (marginally below our estimate of 4.95mt). The realization/tonne declined by 5.8% yoy to `4,276 (below our estimate of `4,345). The EBITDA fell by 21.2% yoy to `310.1cr (in line with our estimate of `318.6cr). The EBITDA/tonne at `633, is down by 22.5% on a yoy basis (in line of our estimate of `643). EBIDTA margin down 317bp yoy: For 3QCY2015, ACEM s top-line fell by 4.2% yoy to `2,095.2cr, impacted by weak demand and fall in realization. The company s volume rose by 1.7% yoy (fell 16.7% qoq) to 4.9mt, while realization was down by 5.8% yoy due to pricing pressure in its key markets of North and West regions. However, the operating performance was in line with our estimates, led by operational efficiency. The company s EBIDTA declined by 21.2% yoy to `310.1cr but was in line with our estimate of `318.9cr. The EBIDTA decline was led by weak realization and increase in other expenses (led by `40cr provision for DMF). Hence the EBIDTA margin, at 14.7%, declined by 317bp yoy, but was in line with our estimate. The Reported PAT fell by 35.8% yoy to `153.6cr (below our estimate of `220.2cr), mainly due to higher depreciation and lower other income. Outlook and valuation: Going forward, we expect ACEM s volume growth to remain under pressure due to lack of capacity, for the next two years. However, we expect the top-line to register an 8.1% CAGR over CY2014-17E. At the current market price, the stock is trading at an EV/tonne of US$150 on CY2017E installed capacity and 10.6x EV/EBIDTA of CY2017E. We maintain our Accumulate rating on the stock with target price of `233 on 12.5x EV/EBIDTA and EV/tonne of US$165 on CY2017E installed capacity. Key financials (Standalone) Y/E Dec. (` cr) CY2013 CY2014 CY2015E CY2016E CY2017E Net sales 9,176 9,978 10,241 11,624 12,616 % chg (6.1) 9.1 2.6 13.8 8.6 Adj. net profit 1,030 1,496 1,026 1,375 1,568 % chg (34.7) 45.3 (31.4) 34.0 14.1 OPM (%) 18.4 19.5 16.8 19.4 20.7 FDEPS (`) 6.7 9.7 6.6 8.9 10.1 P/E (x) 31.1 21.4 31.3 23.3 20.5 P/BV (x) 3.4 3.2 3.1 2.9 2.8 RoE (%) 11.3 15.3 10.0 12.8 13.8 RoCE (%) 11.8 13.3 10.4 14.2 16.0 EV/Sales 3.1 2.8 2.7 2.4 2.2 EV/EBITDA (x) 16.7 14.2 16.2 12.4 10.6 ; Note: CMP as of October 29, 2015 ACCUMULATE CMP Target Price Investment Period Stock Info Sector Market Cap (` cr) Net Debt (` cr) Beta 52 Week High / Low Avg. Daily Volume Face Value (`) BSE Sensex Nifty Reuters Code Bloomberg Code `207 `233 12 Months Please refer to important disclosures at the end of this report 1 Cement 32,396 (4,610) 1.1 287/196 193,085 2 26,838 8,112 ABUJ.BO ACEM@IN Shareholding Pattern (%) Promoters 50.3 MF / Banks / Indian Fls 12.8 FII / NRIs / OCBs 27.1 Indian Public / Others 9.9 Abs. (%) 3m 1yr 3yr Sensex (1.5) 0.6 45.1 ACL (9.4) (6.8) 0.0 3-year price chart 300 280 260 240 220 200 180 160 140 120 100 3QCY2015 Result Update Cement Oct-12 Jan-13 Apr-13 Jul-13 Oct-13 Jan-14 Apr-14 Jul-14 Oct-14 Jan-15 Apr-15 Jul-15 Oct-15 Shrenik Gujrathi 022-39357800 Ext 6872 Shrenik.gujrathi@angelbroking.com October 30, 2015

Exhibit 1: 3QCY2015 performance (Standalone) Y/E Dec. (` cr) 3QCY15 2QCY15 % chg qoq 3QCY14 % chg yoy 9MCY15 9MCY14 % chg Net sales 2,095 2,492.76 (16.0) 2,188 (4.2) 70,125 75,337 (6.9) Other operating income 16 18 (11.4) 15 8.3 719 377 90.5 Total operating income 2,111 2,510 (15.9) 2,202 (4.1) 70,844 75,714 (6.4) Net raw-material costs 109 178 (38.9) 149 (26.7) 4,954 5,532 (10.5) (% of sales) 5.2 7.1 6.8 7.0 7.3 Power & fuel 486 584 (16.8) 510 (4.6) 16,073 17,123 (6.1) (% of sales) 23.0 23.3 23.2 22.7 22.6 Staff costs 151 150 0.9 142 6.4 4,497 4,122 9.1 (% of sales) 7.2 6.0 6.5 6.3 5.4 Freight & forwarding 554 715 (22.5) 548 1.0 18,897 18,952 (0.3) (% of sales) 26.2 28.5 24.9 26.7 25.0 Other expenses 500 499 0.3 459 8.9 14,344 14,045 2.1 (% of sales) 23.7 19.9 20.9 20.2 18.5 Total expenditure 1,801 2,127 (15.3) 1,809 (0.4) 58,763 59,773 (1.7) Operating profit 310 384 (19.2) 393 (21.2) 12,081 15,941 (24.2) OPM (%) 14.7 15.4 (70bp) 17.9 (317)bp 17.1 21.1 (400bp) Interest 21 32 (34.3) 18 16.1 737 542 35.9 Depreciation 155 149 4.5 130 19.3 4,615 3,740 23.4 Other income 74 106 (29.9) 89 (16.3) 2,749 3,585 (23.3) Exceptional Inc./(Exp.) - - - 0 0 PBT 208 309 (32.7) 334 (37.6) 9,478 15,244 (37.8) Provision for taxation 55 83 (34.2) 95 (42.4) 2,460 3,308 (25.6) (% of PBT) 26.2 26.8 28.4 26.0 21.7 Reported PAT 154 226 (32.2) 239 (35.8) 7,018 11,936 (41.2) PATM (%) 7.3 9.0 (174bp) 10.9 (358bp) 9.9 15.8 (586bp) EPS (`) 1.0 1.5 1.5 4.5 7.5 Exhibit 2: Financial performance (` cr) 3,000 2,500 2,000 1,500 1,000 500-21.7 17.9 15.1 588 2,706 2,188 393 358 2,379 2,425 21.0 510 2,493 15.4 14.7 384 310 2QCY14 3QCY14 4QCY14 1QCY15 2QCY15 3QCY15 Net Sales EBITDA EBITDA margin (%) 2,095 (%) 25.0 20.0 15.0 10.0 5.0 0.0 October 30, 2015 2

Exhibit 3: 3QCY2015 Actual vs Angel estimates (` cr) Actual Estimates Variation (%) Net sales 2,095 2,153 (2.7) EBIDTA 310 319 (2.7) EBIDTA Margin (%) 14.7 14.7 - Net profit 154 220 (30.3) Performance highlights Top-line declines 4.2% yoy ACEM s standalone top-line for the quarter fell by 4.2% yoy to `2,095.2cr (marginally below our estimate of `2.152.7cr), impacted by weak demand and higher-than-expected fall in realization. The company registered a volume growth of 1.7% yoy to 4.9mt, but the same was below our estimate of 4.95mt. Realization/tonne was down by 5.8% yoy to `4,276 (below our estimate of `4,345), mainly due to pricing pressure in its key markets of North and West regions. EBIDTA margin down 317bp yoy ACEM s EBIDTA margin fell by 317bp yoy to 14.7% impacted by fall in realization and increase in other expenses (led by `40cr provision for DMF). Total operating expenses were down by 0.4% yoy, led by 26.7% yoy fall in raw material costs and 4.6% yoy fall in power costs. Power costs were down mainly due to lower pet coke and imported coal prices. The EBIDTA declined by 21.2% yoy to `310.1cr and was in line with our estimate of `318.6cr. The EBITDA/tonne was down by 22.5% yoy to `633 (in line with our estimate of `643). Per-tonne analysis For 3QCY2015, ACEM s realization/tonne fell 5.8% on a yoy basis, (up 0.9% qoq). Raw material cost/tonne declined 17.3%/26.6% yoy/qoq. Freight cost/tonne declined by 0.6%/7.1% yoy/qoq to `1,130, led by fall in diesel prices. Power and fuel (P&F) costs/tonne fell by 6.2%/0.2% yoy/qoq to `992. Other expenses/tonne increased 7.1%/20.3% yoy/qoq to `1,021, mainly due to provision related to DMF. The operating profit/tonne stood at `633, down by 22.5% yoy, led by fall in realization and increase in other expenses. Exhibit 4: Per tonne analysis (`/tonne) 3QCY15 3QCY14 2QCY15 % chg (yoy) % chg (qoq) Realization/tonne 4,276 4,538 4,239 (5.8) 0.9 Raw-material cost/tonne 222 269 303 (17.3) (26.6) Power and fuel cost/tonne 992 1,058 994 (6.2) (0.2) Freight cost/tonne 1,130 1,138 1,216 (0.6) (7.1) Other costs/tonne 1,021 953 848 7.1 20.3 Operating costs/tonne 3,675 3,752 3,617 (2.1) 1.6 Operating Profit/tonne 633 816 653 (22.5) (3.0) October 30, 2015 3

Investment rationale Lack of capacity addition impacting top-line growth ACEM has seen a 6.9% yoy decline in its top-line during 9MCY2015, led by soft demand and weak pricing environment in its key markets. There has been a volume de-growth of 4.2% yoy during the same period. Going forward, we believe the company will continue to lose market share as there is no visibility of new capacity addition for the next two years. We expect ACEM s volumes to grow at a CAGR of 4.1% during CY2014-17. Lack of capacity addition would lead to underperformance in terms of volume growth. However cement prices are expected to remain strong on back of demand boost led by government spending on infrastructure, housing and smart cities schemes. Outlook and valuation Going forward, we expect ACEM s volume growth to remain under pressure due to lack of capacity. However, we expect the top-line to register an 8.1% CAGR over CY2014-17E. At the current market price, the stock is trading at an EV/tonne of US$150 on CY2017E capacity and 10.6x EV/EBIDTA of CY2017E. We maintain our Accumulate rating on the stock with a target price of `233 on 12.5x EV/EBIDTA and EV/tonne of US$165 on CY2017E installed capacity. October 30, 2015 4

Company Background Swiss cement major, Holcim acquired a controlling stake in ACEM in 2005. In India, the Holcim Group currently controls one-fifth of the total cement capacity through ACEM and ACC. On a standalone basis, ACEM is the third largest cement player in India with total capacity of 27mtpa. The company majorly focuses on northern and western India, with no plants in southern India. Of its current total capacity, 40% capacity is in the western, 38% in northern, 16% in eastern and northeastern and 6% capacity is in the central region of the country. October 30, 2015 5

Profit & loss statement (Standalone) Y/E December (` cr) CY2013 CY2014 CY2015E CY2016E CY2017E Net Sales 9,087 9,911 10,166 11,564 12,556 Other operating income 90 67 74 60 60 Total operating income 9,176 9,978 10,241 11,624 12,616 % chg (5.8) 8.7 2.6 13.5 8.5 Total Expenditure 7,509 8,050 8,532 9,382 10,018 Net Raw Materials 765 810 820 928 1,012 Other Mfg costs 2,063 2,265 2,337 2,544 2,699 Personnel 502 582 640 704 760 Other 4,179 4,393 4,736 5,205 5,547 EBITDA 1,668 1,928 1,708 2,242 2,598 % chg (32.9) 15.6 (11.4) 31.3 15.9 (% of Net Sales) 18.4 19.5 16.8 19.4 20.7 Depreciation& Amortisation 490 510 545 594 643 EBIT 1,178 1,419 1,163 1,648 1,955 % chg (38.7) 20.5 (18.0) 41.7 18.6 (% of Net Sales) 13.0 14.3 11.4 14.3 15.6 Interest & other Charges 65 64 71 76 76 Other Income 378 429 440 480 462 (% of PBT) 25 24 29 23 20 Recurring PBT 1,490 1,783 1,531 2,052 2,341 % chg (31.7) 19.7 (14.1) 34.0 14.1 Extraordinary Expense/(Inc.) (266) - - - - PBT (reported) 1,756 1,783 1,531 2,052 2,341 Tax 460 287 505 677 772 (% of PBT) 26.2 16.1 33.0 33.0 33.0 PAT (reported) 1,295 1,496 1,026 1,375 1,568 ADJ. PAT 1,030 1,496 1,026 1,375 1,568 % chg (34.7) 45.3 (31.4) 34.0 14.1 (% of Net Sales) 11.3 15.1 10.1 11.9 12.5 Basic EPS (`) 6.7 9.7 6.6 8.9 10.1 Fully Diluted EPS (`) 6.7 9.7 6.6 8.9 10.1 October 30, 2015 6

Balance sheet (Standalone) Y/E December (` cr) CY2013 CY2014 CY2015E CY2016E CY2017E SOURCES OF FUNDS Equity Share Capital 309 310 310 310 310 Preference Capital - - - - - Reserves& Surplus 9,176 9,793 10,188 10,716 11,319 Shareholders Funds 9,486 10,103 10,498 11,026 11,629 Total Loans 40 21 21 21 21 Deferred Tax Liability 564 589 589 589 589 Other Long term liabilities 18 18 18 18 18 Long term provisions 248 248 248 248 248 Total Liabilities 10,356 10,979 11,373 11,902 12,504 APPLICATION OF FUNDS Gross Block 10,826 11,429 12,229 13,329 14,429 Less: Acc. Depreciation 4,764 5,202 5,747 6,341 6,985 Net Block 6,063 6,227 6,482 6,988 7,444 Capital Work-in-Progress 695 690 890 790 490 Other non current assets - 289 289 289 289 Intangible assets - - - - - Investments 1,788 2,173 2,173 2,173 2,173 Long term loans and advances 647 647 647 647 647 Current Assets 3,771 3,874 3,660 3,963 4,587 Cash 2,341 2,458 1,971 1,986 2,445 Loans & Advances 208 254 287 332 383 Other 1,223 1,162 1,402 1,645 1,760 Current liabilities 2,609 2,922 2,769 2,948 3,126 Net Current Assets 1,163 952 892 1,014 1,461 Mis. Exp. not written off - - - - - Total Assets 10,356 10,979 11,373 11,902 12,504 October 30, 2015 7

Cash flow statement (Standalone) Y/E December (` cr) CY2013 CY2014 CY2015E CY2016E CY2017E Profit before tax 1,756 1,783 1,531 2,052 2,341 Depreciation 490 510 545 594 643 (Inc)/Dec in Working Capital (150) 328 (427) (108) 12 Add: Interest expenses 65 64 71 76 76 Less: Other income 378 429 440 480 462 Less: Direct taxes paid 460 287 505 677 772 Cash Flow from Operations 1,322 1,969 776 1,457 1,838 (Inc)/ Dec in Fixed Assets (885) (598) (1,000) (1,000) (800) (Inc)/ Dec in Investments (133) (384) - - - Other income 378 429 440 480 462 Cash Flow from Investing (640) (553) (560) (520) (338) Issue of Equity 42 52 - - - Inc./(Dec.) in loans (2) (20) - - - Dividend Paid (Incl. Tax) 651 921 632 846 965 Others (16) 409 71 76 76 Cash Flow from Financing (595) (1,298) (703) (922) (1,041) Inc./(Dec.) in Cash 88 117 (487) 15 459 Opening Cash balances 2,253 2,341 2,458 1,971 1,986 Closing Cash balances 2,341 2,458 1,972 1,986 2,445 October 30, 2015 8

Key ratios Y/E December CY2013 CY2014 CY2015E CY2016E CY2017E Valuation Ratio (x) P/E (on FDEPS) 31.1 21.4 31.3 23.3 20.5 P/CEPS 17.9 16.0 20.4 16.3 14.5 P/BV 3.4 3.2 3.1 2.9 2.8 Dividend yield (%) 1.7 2.4 1.7 2.2 2.5 EV/Sales 3.1 2.8 2.7 2.4 2.2 EV/EBITDA 16.7 14.2 16.2 12.4 10.6 EV / Total Assets 2.7 2.5 2.4 2.3 2.2 Per Share Data (`) EPS (Basic) 6.7 9.7 6.6 8.9 10.1 EPS (fully diluted) 6.7 9.7 6.6 8.9 10.1 Cash EPS 11.5 12.9 10.1 12.7 14.3 DPS 3.6 5.0 3.4 4.6 5.2 Book Value 61.4 65.2 67.7 71.1 75.0 Dupont Analysis EBIT margin 12.8 14.2 11.4 14.2 15.5 Tax retention ratio 73.8 83.9 67.0 67.0 67.0 Asset turnover (x) 1.2 1.2 1.1 1.2 1.3 ROIC (Post-tax) 11.3 14.4 8.7 11.4 13.1 Returns (%) ROCE (Pre-tax) 11.8 13.3 10.4 14.2 16.0 Angel ROIC (Pre-tax) 16.6 18.7 14.2 18.7 20.9 ROE 11.3 15.3 10.0 12.8 13.8 Turnover ratios (x) Asset Turnover (Gross Block) 0.9 0.9 0.9 0.9 0.9 Inventory / Sales (days) 38 33 35 38 39 Receivables (days) 9 8 9 9 9 Payables (days) 129 125 122 111 111 WC cycle (ex-cash) (days) (50) (49) (46) (32) (28) Solvency ratios (x) Net debt to equity (0.2) (0.2) (0.2) (0.2) (0.2) Net debt to EBITDA (1.4) (1.3) (1.1) (0.9) (0.9) Interest Coverage (EBIT / Int.) 18.1 22.0 16.3 21.6 25.6 October 30, 2015 9

Research Team Tel: 022-39357800 E-mail: research@angelbroking.com Website: www.angelbroking.com DISCLAIMER Angel Broking Private Limited (hereinafter referred to as Angel ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and Metropolitan Stock Exchange of India Limited. It is also registered as a Depository Participant with CDSL and Portfolio Manager with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel Broking Private Limited is a registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration number INH000000164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. Angel or its associates including its relatives/analyst do not hold any financial interest/beneficial ownership of more than 1% in the company covered by Analyst. Angel or its associates/analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. Angel/analyst has not served as an officer, director or employee of company covered by Analyst and has not been engaged in market making activity of the company covered by Analyst. This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Pvt. Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Pvt. Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Pvt. Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Neither Angel Broking Pvt. Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Note: Please refer to the important Stock Holding Disclosure' report on the Angel website (Research Section). Also, please refer to the latest update on respective stocks for the disclosure status in respect of those stocks. Angel Broking Pvt. Limited and its affiliates may have investment positions in the stocks recommended in this report. Disclosure of Interest Statement Ambuja Cements 1. Analyst ownership of the stock No 2. Angel and its Group companies ownership of the stock No 3. Angel and its Group companies' Directors ownership of the stock No 4. Broking relationship with company covered No Note: We have not considered any Exposure below ` 1 lakh for Angel, its Group companies and Directors Ratings (Based on expected returns Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%) over 12 months investment period): Reduce (-5% to -15%) Sell (< -15) October 30, 2015 10